📞Call us
+91 80629 16290
Akums Drugs & Pharmaceuticals Ltd.
₹692.1
5.1 (0.7%)
AKUMS Share Price
As on July 15, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 10,518 Cr
P/E Ratio41.21
Dividend Yield0.22 %
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open695
High704.75
NSE SymbolAKUMS
Close692.1
Low683
BSE Symbol544222
Previous Years High/Low
1 Year High714.7
3 Year High1,175.9
5 Year High1,175.9
1 Year Low409.3
3 Year Low405
5 Year Low405
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 684.61 | Bullish |
| 10-DMA | 660.9 | Bullish |
| 20-DMA | 637.25 | Bullish |
| 50-DMA | 583.13 | Bullish |
| 100-DMA | 541.02 | Bullish |
| 200-DMA | 492.25 | Bullish |
Historical Performance
1 Year
24.3%
3 Years
N/A
5 Years
N/A
10 Years
N/A
Shareholding Pattern
%
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 43,590 | 41,182 | 41,782 | 36,548 | 36,719 |
| Total Expenditure | 38,370 | 36,575 | 40,552 | 33,608 | 37,636 |
| Other Income | 1,287 | 560 | 340 | 901 | 226 |
| Operating Profit | 6,507 | 5,166 | 1,570 | 3,841 | -691 |
| Interest | 941 | 346 | 506 | 462 | 167 |
| Depreciation | 1,546 | 1,534 | 1,256 | 1,128 | 947 |
| Profit Before Tax | 3,821 | 3,453 | -453 | 1,503 | -1,932 |
| Consolidated Net Profit | 2,552 | 3,382 | -40 | 949 | -2,525 |
| Adjusted EPS | 17 | 22 | --- | 7 | -18 |
Compounded Sales Growth
10 Years:21.4
5 Years:9.9
3 Years:3.6
TTM:1.1
Compounded Profit Growth
10 Years:32.9
5 Years:15.8
3 Years:21.9
TTM:-5.5
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:23.3
Return on Equity
10 Years:7.4
5 Years:-17.7
3 Years:-0.3
last year:16.7
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 306 | 306 | 286 | 286 | 143 |
| Total Reserves | 32,827 | 30,164 | 6,809 | 6,886 | 6,077 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 8,502 | -520 | 14,623 | 12,461 | 11,526 |
| Other Current Liabilities | 3,453 | 1,797 | 2,527 | 2,462 | 2,381 |
| Short Term Borrowings | 730 | 137 | 3,677 | 3,876 | 3,379 |
| Total Liabilities | 52,761 | 39,054 | 33,933 | 32,350 | 30,502 |
| Capital Work in Progress | 1,767 | 1,596 | 1,951 | 1,030 | 308 |
| Long Term Loans & Advances | 759 | 614 | 564 | 964 | 861 |
| Currents Investments | --- | --- | --- | --- | --- |
| Short Term Loans and Advances | 3,035 | 2,150 | 1,694 | 1,393 | 1,450 |
| Total Current Assets | 35,599 | 22,746 | 19,408 | 18,789 | 18,641 |
| Total Assets | 52,761 | 39,054 | 33,933 | 32,350 | 30,502 |
| Adjusted Book Value | 216 | 199 | 50 | 50 | 43 |
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a high PE of 41.21, indicating expensive valuation or elevated growth expectations.
- Over the last three years, the stock delivered a weak 3-year price CAGR of -13.7%, indicating poor shareholder returns.
- The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
- In the last financial year, the company reported an EBITDA of ₹6507 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹43590 million, indicating a large and established business.
Investment Calculator
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1232371.8
No. of Shares: 1781 (Approx)
Performance:23.2%
232371.8
NIFTY Performance: -4.5%
1 day Top Gainers
| Symbol | Change% |
|---|---|
| NUVOCO | 377.25(11%) |
| AEGISLOG | 1321.1(8%) |
| ATHERENERG | 1296.4(8%) |
| LTTS | 3508.3(7%) |
| INOXINDIA | 1964.4(6%) |
1 Day Top Losers
| Symbol | Change% |
|---|---|
| PATANJALI | 347.9(-15%) |
| TATAELXSI | 3520.4(-5%) |
| DBREALTY | 116.87(-5%) |
| ADANIPOWER | 218.97(-3%) |
| ADANIGREEN | 1555.4(-3%) |
| GODIGIT | 298.65(-3%) |
| JSWINFRA | 337.35(-3%) |
| ZENSARTECH | 513.1(-3%) |
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
